322 related articles for article (PubMed ID: 35503461)
1. The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.
Pepper NB; Stummer W; Eich HT
Strahlenther Onkol; 2022 Jun; 198(6):507-526. PubMed ID: 35503461
[TBL] [Abstract][Full Text] [Related]
2. A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme.
Julka PK; Awasthy BS; Rath GK; Agarwal S; Varna T; Mahapatra AK; Singh R
Australas Radiol; 2000 Feb; 44(1):84-7. PubMed ID: 10761264
[TBL] [Abstract][Full Text] [Related]
3. GBM radiosensitizers: dead in the water…or just the beginning?
Bindra RS; Chalmers AJ; Evans S; Dewhirst M
J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme.
Choi J; Kim G; Cho SB; Im HJ
J Nanobiotechnology; 2020 Sep; 18(1):122. PubMed ID: 32883290
[TBL] [Abstract][Full Text] [Related]
5. Potential usefulness of radiosensitizers in glioblastoma.
Harasaki Y; Waziri A
Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
Li R; Wang H; Liang Q; Chen L; Ren J
Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
8. [Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
Hoshino T
Rinsho Hoshasen; 1968 Nov; 13(11):885-91. PubMed ID: 4304555
[No Abstract] [Full Text] [Related]
9. Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.
Matsutani M; Nakamura O; Nakamura M; Nagashima T; Asai A; Fujimaki T; Tanaka H; Ueki K; Tanaka Y
J Neurooncol; 1994; 19(3):227-37. PubMed ID: 7807173
[TBL] [Abstract][Full Text] [Related]
10. Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma.
Degorre C; Tofilon P; Camphausen K; Mathen P
Radiat Oncol; 2021 Sep; 16(1):191. PubMed ID: 34583727
[TBL] [Abstract][Full Text] [Related]
11. Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.
Rodriguez R; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):859-62; discussion 865. PubMed ID: 1651310
[No Abstract] [Full Text] [Related]
12. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.
Carlson BL; Grogan PT; Mladek AC; Schroeder MA; Kitange GJ; Decker PA; Giannini C; Wu W; Ballman KA; James CD; Sarkaria JN
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):212-9. PubMed ID: 19695438
[TBL] [Abstract][Full Text] [Related]
15. DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma.
Roberto GM; Paiva HH; Botelho de Souza LE; Pezuk JA; Vieira GM; de Oliveira HF; Umezawa K; Tone LG; Brassesco MS
Anticancer Agents Med Chem; 2018; 18(9):1323-1329. PubMed ID: 29683097
[TBL] [Abstract][Full Text] [Related]
16. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
van Nifterik KA; van den Berg J; Stalpers LJ; Lafleur MV; Leenstra S; Slotman BJ; Hulsebos TJ; Sminia P
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1246-53. PubMed ID: 17967314
[TBL] [Abstract][Full Text] [Related]
17. Experimental and clinical studies on radiation and curcumin in human glioma.
Sminia P; van den Berg J; van Kootwijk A; Hageman E; Slotman BJ; Verbakel WFAR
J Cancer Res Clin Oncol; 2021 Feb; 147(2):403-409. PubMed ID: 33118056
[TBL] [Abstract][Full Text] [Related]
18. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.
Chamberlain MC; Glantz MJ; Chalmers L; Van Horn A; Sloan AE
J Neurooncol; 2007 Mar; 82(1):81-3. PubMed ID: 16944309
[TBL] [Abstract][Full Text] [Related]
19. Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma.
Ruiz-Garcia H; Ramirez-Loera C; Malouff TD; Seneviratne DS; Palmer JD; Trifiletti DM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575840
[TBL] [Abstract][Full Text] [Related]
20. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.
Clarke JW; Chang EL; Levin VA; Mayr NA; Hong E; Cavaliere R; Lo SS
Expert Rev Anticancer Ther; 2008 May; 8(5):733-41. PubMed ID: 18471046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
